JSP Pharmaceutical Manufacturing (Thailand) PCL. inform the resolution of the Board of Directors on 28 June 2022, which significant resolution was approval of a new subsidiary establishment with details as follow: Company name: Caresutic Company Limited. Business description: (1) Innovation Center to perform research and development.

in dietary supplements and cosmetics. Small-scale production facility of dietary supplements and cosmetics. Registered capital, number of shares and par value: THB 5.00 million, divided to be 50,000 shares with par value of THB 100 per share.

Name of directors: Mrs. Jintana Santipisud, Mr. Sittichai Daengprasert, Ms. Jirada Daengprasert. To compute transaction size, the company used financial information presented in the Company's interim financial information as of 31 March 2022. The highest transaction size was 0.54% based on net tangible assets.

In connection with acquisition of assets in the last six months, the highest transaction size was 11.15% based on total value of consideration. In conclusion, this transaction is not required to perform under the Notification of the Capital Market Supervisory Board No. Tor Chor 20/2551 and is not a connected transaction.

However, this transaction is considered as acquisition of investment in other company; which results other company becomes a subsidiary of a listed company, in accordance with the Regulations of the Stock Exchange of Thailand Re: Rules, Conditions and Procedures Governing the Disclosure of Information and Other Acts of a Listed Company.